BeStock  
Stocks › Biotechnology › ERAS

Erasca ERAS

US equityMarket cap rank #2084Biotechnology
$13.61 −$0.61 (-4.29%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $13.74 +0.96%
Open$13.13
Prev close$14.22
Day range$13.13 – $14.31
Volume11.07M
Market cap$4.78B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-16.1x
CheapRich

Near the bottom of its 5-year range · 12th percentile, 5-year average -6.6x

Price / book6.0x
CheapRich

Near the top of its 5-year range · 83rd percentile, 5-year average 3.7x

#4564 of 5331 stocks by PB (1 = cheapest)

P/E over five years

-53x-33x-14x6xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$20.96
Price vs. fair value-35.1%Trading below the estimate
Star rating★★★★☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 6.00 – 3.68 83% (pricier than usual) #4564 of 5331 (1 = cheapest)
PE -16.14 -22.27 -6.60 12% (cheaper than usual) –
PS – – 0.00 – –

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on ERAS.

Sign in to join the discussion.

Scroll to Top